Literature DB >> 2320753

Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses.

W Dörr1, J Kummermehr.   

Abstract

Mouse tongue mucosa was established as an animal model to study repopulation after large single doses or during continuous irradiation. A top-up irradiation technique was used employing priming doses or fractionated treatment to the whole snout (300 kV X-rays) followed by local test doses (25 kV X-rays) to elicit denudation in a confined field of the inferior tongue surface. Clearcut quantal dose-response curves of ulcer incidence were obtained to all protocols; animal morbidity, i.e. body weight loss was minimal. Repopulation following priming doses of 10 and 13 Gy started with a delay of at least 3 days and then progressed rapidly to nearly restore original tissue tolerance by day 11. During continuous fractionation over 1 to 3 weeks with 5 fractions/week and doses per fraction of 2.5, 3 and 3.5 Gy, repopulation was small in week one but subsequently increased to fully compensate the weekly dose at all dose levels. Additional measurements of cell density during a 4 weeks course of 5 x 3 Gy or 5 x 4 Gy per week showed only moderate depletion to 67% of the control figures. The fact that rapid repopulation is achieved at relatively moderate damage levels should be taken into account when the timing of a treatment split is considered.

Entities:  

Mesh:

Year:  1990        PMID: 2320753     DOI: 10.1016/0167-8140(90)90209-f

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Solid tumor risks after high doses of ionizing radiation.

Authors:  Rainer K Sachs; David J Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

2.  Model of accelerated carcinogenesis based on proliferative stress and inflammation for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Brigitte Schäfer
Journal:  Radiat Environ Biophys       Date:  2012-08-17       Impact factor: 1.925

3.  Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation.

Authors:  M Schmidt; J Haagen; R Noack; A Siegemund; P Gabriel; W Dörr
Journal:  Strahlenther Onkol       Date:  2014-01-24       Impact factor: 3.621

4.  [A century of development in radiation biology. Basic principles of targeted and efficient radiotherapy].

Authors:  C Streffer; T Herrmannn
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

5.  Boron neutron capture therapy: effects of split dose and overall treatment time.

Authors:  G M Morris; P L Micca; M Rezvani; J W Hopewell; J A Coderre
Journal:  J Neurooncol       Date:  2001-04       Impact factor: 4.130

6.  Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaks.

Authors:  Li-Jeen Mah; Christian Orlowski; Katherine Ververis; Raja S Vasireddy; Assam El-Osta; Tom C Karagiannis
Journal:  Genome Integr       Date:  2011-01-25

7.  R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/beta-catenin pathway.

Authors:  Jingsong Zhao; Kyung-Ah Kim; Josephine De Vera; Servando Palencia; Marie Wagle; Arie Abo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-29       Impact factor: 11.205

8.  Radiation-induced oral mucositis in mice: strain differences.

Authors:  W Dörr; K Spekl; M Martin
Journal:  Cell Prolif       Date:  2002-08       Impact factor: 6.831

9.  A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach.

Authors:  Igor Shuryak; Philip Hahnfeldt; Lynn Hlatky; Rainer K Sachs; David J Brenner
Journal:  Radiat Environ Biophys       Date:  2009-06-18       Impact factor: 1.925

Review 10.  Review of preclinical studies on treatment of mucositis and associated pain.

Authors:  C T Viet; P M Corby; A Akinwande; B L Schmidt
Journal:  J Dent Res       Date:  2014-06-18       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.